Question
Download Solution PDFWhat is the name of the new drug developed by scientists recently as an alternative to antibiotics?
This question was previously asked in
TSPSC Steno, Typist & Junior Assistant 2017 (Paper I) Official Paper
Answer (Detailed Solution Below)
Option 1 : Staphefekt
Free Tests
View all Free tests >
Narendra Modi 3.0: Cabinet Minister's
3.8 K Users
25 Questions
25 Marks
15 Mins
Detailed Solution
Download Solution PDFThe correct answer is Staphefekt.
Key Points
- Staphefekt
- It is a proprietary enzyme used to treat Staphylococcus aureus skin infections in humans.
- It was developed and produced by Micreos, a Dutch biotechnology company.
- It was the first commercially available endolysin.
- It is marketed in Gladskin products.
- The enzyme is effective in killing Staphylococcus aureus strains resistant to antibiotics.
- It is also successfully used for the treatment of Staphylococcus aureus-related dermatosis.
Additional Information
- Antibiotics
- It is an antimicrobial substance that is active against bacteria.
- They are used to treat bacterial infections when prescribed by a health professional.
- It may either kill or inhibit bacterial growth.
- Antibiotics are not effective against influenza viruses.
- The full course of treatment should be completed and should not be saved for future purposes.
Last updated on Jun 14, 2025
-> TSPSC Group 3 CV Round has been postponed. The Certificate Verification Dates will be announced soon on the official website.
-> TSPSC Group 3 result 2025 had been released on 14th march 2025.
-> Earlier, TSPSC Group 3 vacancies were revised for the post of Junior Assistant (HO).
-> The TSPSC Group 3 vacancies were revised to 1375. Now, 13 more vacancies are added and the total vacancies for TSPSC Group 3 are now 1388.